206 related articles for article (PubMed ID: 20357373)
21. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
[TBL] [Abstract][Full Text] [Related]
22. Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy.
Sosenko JM; Sparling YH; Hu D; Welty T; Howard BV; Lee E; Robbins DC
Diabetes Care; 1999 Oct; 22(10):1715-21. PubMed ID: 10526741
[TBL] [Abstract][Full Text] [Related]
23. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes.
Meijer JW; van Sonderen E; Blaauwwiekel EE; Smit AJ; Groothoff JW; Eisma WH; Links TP
Diabetes Care; 2000 Jun; 23(6):750-3. PubMed ID: 10840990
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review.
Dros J; Wewerinke A; Bindels PJ; van Weert HC
Ann Fam Med; 2009; 7(6):555-8. PubMed ID: 19901316
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of the 5.07 monofilament test for diabetes polyneuropathy: influence of age, sex, neuropathic pain and neuropathy severity.
Dunker Ø; Uglem M; Bu Kvaløy M; Løseth S; Hjelland IE; Allen SM; Dehli Vigeland M; Kleggetveit IP; Sand T; Nilsen KB
BMJ Open Diabetes Res Care; 2023 Nov; 11(6):. PubMed ID: 37989346
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
27. In vivo corneal confocal microscopy and prediction of future-incident neuropathy in type 1 diabetes: a preliminary longitudinal analysis.
Lovblom LE; Halpern EM; Wu T; Kelly D; Ahmed A; Boulet G; Orszag A; Ng E; Ngo M; Bril V; Perkins BA
Can J Diabetes; 2015 Oct; 39(5):390-7. PubMed ID: 25936902
[TBL] [Abstract][Full Text] [Related]
28. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.
Dimitrakoudis D; Bril V
Neurology; 2002 Aug; 59(4):611-3. PubMed ID: 12196660
[TBL] [Abstract][Full Text] [Related]
29. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
[TBL] [Abstract][Full Text] [Related]
30. Screening for peripheral neuropathies in children with diabetes: a systematic review.
Hirschfeld G; von Glischinski M; Blankenburg M; Zernikow B
Pediatrics; 2014 May; 133(5):e1324-30. PubMed ID: 24709928
[TBL] [Abstract][Full Text] [Related]
31. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".
Jurado J; Ybarra J; Pou JM
Nurs Clin North Am; 2007 Mar; 42(1):59-66. PubMed ID: 17270590
[TBL] [Abstract][Full Text] [Related]
32. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of heart-rate recovery after exercise in the assessment of diabetic cardiac autonomic neuropathy.
Sacre JW; Jellis CL; Coombes JS; Marwick TH
Diabet Med; 2012 Sep; 29(9):e312-20. PubMed ID: 22671998
[TBL] [Abstract][Full Text] [Related]
34. Four-year Incident Neuropathy and its Risk Factors in Subjects with Type 2 Diabetes.
Srinivasan S; Raman R; Kulothungan V; Pal SS; Roy R; Ganesan S; Sharma T
J Assoc Physicians India; 2019 Jul; 67(7):34-37. PubMed ID: 31559766
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence of peripheral neuropathy among primary care type 2 diabetic patients].
Ibarra CT; Rocha Jde J; Hernández RO; Nieves RE; Leyva RJ
Rev Med Chil; 2012 Sep; 140(9):1126-31. PubMed ID: 23354633
[TBL] [Abstract][Full Text] [Related]
36. The accuracy of 10 g monofilament use for clinical screening of diabetes peripheral neuropathy among Indian population.
Hazari A; Mishra V; Kumar P; Maiya A
PLoS One; 2024; 19(2):e0297110. PubMed ID: 38394307
[TBL] [Abstract][Full Text] [Related]
37. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
[TBL] [Abstract][Full Text] [Related]
38. The 'VPTscore'--a useful predictor of neuropathy in diabetic patients.
Coppini DV; Weng C; Young PJ; Sönksen PH
Diabet Med; 2000 Jun; 17(6):488-90. PubMed ID: 10975223
[No Abstract] [Full Text] [Related]
39. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
Zografou I; Iliadis F; Sambanis C; Didangelos T
Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
[TBL] [Abstract][Full Text] [Related]
40. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument.
Barbosa M; Saavedra A; Severo M; Maier C; Carvalho D
Pain Pract; 2017 Apr; 17(4):514-521. PubMed ID: 27538385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
